New Agents Provide Better Treatment for Plaque Psoriasis

Video

The days of patients with plaque psoriasis being treated with tar and special lights are fading as new agents, especially oral agents, are being developed.

The days of patients with plaque psoriasis being treated with tar and special lights are fading as new agents, especially oral agents, are being developed.

Laura Korb Ferris, MD, PhD, from UPMC discussed some of these new treatments during a recent interview with MDMagazine. Because these new treatments are more targeted and because there are more oral agents as opposed to injections Ferris said patients are much happier using them. The newer treatments also help provide more of a gap between the time patients need to see their doctors.

Recent Videos
Discussing Post-Hoc Data on Ruxolitinib for Nonsegmental Vitiligo, with David Rosmarin, MD
Linda Stein Gold, MD, and Bruce Strober, MD, PhD
Linda Stein Gold, MD, and Bruce Strober, MD, PhD
Linda Stein Gold, MD, and Bruce Strober, MD, PhD
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
© 2024 MJH Life Sciences

All rights reserved.